General
|
RAC |
Re:
General Comments / Chat
|
|
rwbro
|
11K |
3.8M |
4 |
15/09/23 |
15/09/23 |
General
|
11K
|
3.8M
|
4
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
rwbro
|
11K |
3.8M |
17 |
20/08/23 |
20/08/23 |
General
|
11K
|
3.8M
|
17
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Strategic Update August 2023
|
|
rwbro
|
592 |
187K |
24 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
592
|
187K
|
24
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
rwbro
|
21K |
7.3M |
5 |
14/06/23 |
14/06/23 |
ASX - By Stock
|
21K
|
7.3M
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race appoints Dr Michelle Rashford Chief Medical Officer
|
|
rwbro
|
32 |
12K |
3 |
09/05/23 |
09/05/23 |
ASX - By Stock
|
32
|
12K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race appoints Dr Michelle Rashford Chief Medical Officer
|
|
rwbro
|
32 |
12K |
8 |
09/05/23 |
09/05/23 |
ASX - By Stock
|
32
|
12K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
rwbro
|
2.2K |
737K |
49 |
08/05/23 |
08/05/23 |
ASX - By Stock
|
2.2K
|
737K
|
49
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
rwbro
|
133 |
39K |
17 |
28/04/23 |
28/04/23 |
ASX - By Stock
|
133
|
39K
|
17
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
rwbro
|
133 |
39K |
11 |
28/04/23 |
28/04/23 |
ASX - By Stock
|
133
|
39K
|
11
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene Protects Mouse Hearts from Chemotherapy Damage
|
|
rwbro
|
112 |
41K |
45 |
09/02/23 |
09/02/23 |
ASX - By Stock
|
112
|
41K
|
45
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Appendix 4E & Annual Report
|
|
rwbro
|
33 |
14K |
9 |
26/08/22 |
26/08/22 |
ASX - By Stock
|
33
|
14K
|
9
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Announces On-Market Share Buyback
|
|
rwbro
|
215 |
73K |
34 |
10/06/22 |
10/06/22 |
ASX - By Stock
|
215
|
73K
|
34
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
rwbro
|
11K |
3.8M |
7 |
19/07/21 |
19/07/21 |
General
|
11K
|
3.8M
|
7
|
|